|
Antibe Therapeutics Inc. - Other Documents & Notices
Fourth Sale Process Letter Update |
November 7, 2024 |
The Fourth Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by seven (7) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe.
|
|
Third Sale Process Letter Update |
October 16, 2024 |
The Third Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by twenty-two (22) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe.
|
|
Second Sale Process Letter Update |
September 17, 2024 |
The Second Sale Process Letter Update provides notification that certain milestone dates for the court-approved sale process in respect of Antibe have been extended by twenty-nine (29) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe.
|
|
Sale Process Letter Update |
July 29, 2024 |
The Sale Process Letter Update provides notification that milestone dates for the court-approved sale process in respect of Antibe Therapeutics Inc. ("Antibe") have been extended by fourteen (14) days at the direction of FTI Consulting Canada Inc. in its capacity as the court-appointed receiver and manager of Antibe.
|
|
Notice and Statement of the Receiver |
April 30, 2024 |
|
|
|
|